|
DIABETES,
OXIDATIVE STRESS AND PHYSICAL EXERCISE
Department
of Physiology, University of Kuopio, Kuopio, 70211 Kuopio, Finland
| Received |
|
01
February 2002 |
| Accepted |
|
18
February 2002 |
| Published |
|
04 March 2002 |
©
Journal of Sports Science and Medicine (2002) 1, 1-14
Search
Google Scholar for Citing Articles
|
|
|
| ABSTRACT
|
|
Outline |
|
Oxidative stress, an imbalance between the generation
of reactive oxygen species and antioxidant defense capacity of the body,
is closely associated with aging and a number of diseases including cancer,
cardiovascular diseases, diabetes and diabetic complications. Several
mechanisms may cause oxidative insult in diabetes, although their exact
contributions are not entirely clear. Accumulating evidence points to
many interrelated mechanisms that increase production of reactive oxygen
and nitrogen species or decrease antioxidant protection in diabetic patients.
In modern medicine, regular physical exercise is an important tool in
the prevention and treatment of diseases including diabetes. Although
acute exhaustive exercise increases oxidative stress, exercise training
has been shown to up regulate antioxidant protection. This review aims
to summarize the mechanisms of increased oxidative stress in diabetes
and with respect to acute and chronic exercise.
KEY WORDS: Diabetes, physical activity, antioxidants, reactive
oxygen species.
DİYABET, OKSİDATİF STRES VE FİZİKSEL EGZERSİZ
ÖZET
Oksidatif stres oksidan oluşumu ve antioksidan savunma
arasındaki dengenin oksidanlar yönünde bozulması durumudur. Oksidatif
stres; yaşlanma, kanser, kalp hastalıkları, diyabet ve diyabetin komplikasyonları
başta olmak üzere pek çok patolojik tablonun ve de yaşlanmanın patogenezi
ile yakın ilişkidedir. Diyabette oksidatif stres pek çok mekanizmaya bağli
olarak artabilmektedir, ancak bu mekanizmalarin kesin katkısı tam olarak
ispatlanabilmiş degildir. Çok sayıdaki deneysel bulgular artan reaktif
oksijen ve nitrojen türlerinin oluşumunun ve zayıflayan antioksidan savunmanın
bu karmaşık mekanizmaların temelini oluşturduğunu göstermektedir. Düzenli
fiziksel aktivite modern tıpta, diabetes de dahil olmak üzere pek çok
hastalıkta tedavi ve koruyucu amaçlı olarak kullanılmaktadır. Her ne kadar
akut fiziksel egzersiz oksidatif stressi artırsa da, düzenli egzersiz
programları antioksidan savunmayı kuvvetlendirmektedir. Bu derlemede diyabette
artmış olan oksidatif stres nedenlerini, akut egzersiz ve düzenli fiziksel
aktivite yönlerinden özetlemeye çalıştık.
ANAHTAR KELiMELER: Diyabet, fiziksel aktivite,
antioksidan, reaktif oksijen.
|
|
|
| INTRODUCTION |
|
Outline |
|
During moderate exercise oxygen consumption increases by 8-10 folds,
and oxygen flux through the muscle may increase by 90-100 folds. Even
moderate exercise may increase free radical production and overwhelm antioxidant
defenses, resulting in oxidative insult (Sen and Packer,
2000).
It was first shown in 1978 by Dillard et al (Dillard
et al., 1978)
that in humans, even a moderate intensity of exercise increased the content
of pentane, a lipid peroxidation byproduct, in expired air. 1982
Davies et al. for the first time provided the direct evidence using electron
paramagnetic resonance spectroscopy. In rats exhaustive treadmill exercise
increased the free radical concentration by 2- to 3-fold of skeletal muscle
and liver (Davies et al., 1982).
Further studies of our group and several other groups demonstrated that
strenuous exercise induces oxidative stress as measured by oxidative damage
of lipids, proteins and even the genetic material (Sen
et al., 1994a;
Goldfarb et al., 1996;
Tiidus et al., 1996;
Khanna et al., 1999;
Ji, 1999;
Atalay and Sen, 1999;
Sen, 1999;
Sen et al., 2000;
Atalay et al., 2000;
Selamoglu et al., 2000).
On the other hand, exercise training - both endurance and interval type
- appears to induce antioxidant protection and decrease oxidative insult.
Thus regular physical exercise protects against exercise induced oxidative
stress (Atalay et al., 1996a;
1996b;
Powers et al., 1997;
1999;
Khanna et al., 1999;
Sen, 1999).
Diabetes mellitus (DM) is a syndrome characterized by abnormal insulin
secretion, derangement in carbohydrate and lipid metabolism, and is diagnosed
by the presence of hyperglycemia. Diabetes is a major worldwide health
problem predisposing to markedly increased cardiovascular mortality and
serious morbidity and mortality related to development of nephropathy,
neuropathy and retinopathy (Zimmet et al., 1997).
The prevalence of type 2 DM among adults varies from less than 5% to over
40% depending on the population in question (Zimmet
et al., 1997).
Due to increasing obesity, sedentariness and dietary habits in both Western
and developing countries, the prevalence of type 2 DM is growing at an
exponential rate (Zimmet and Lefebvre, 1996).
Increased oxidative stress as measured by indices of lipid peroxidation
and protein oxidation has been shown to be increased in both insulin dependent
diabetes (IDDM), and non-insulin dependent (NIDDM) (Sato
et al., 1979;
Velazquez et al., 1991;
Collier et al., 1992;
MacRury et al., 1993;
Neri et al., 1994;
Yaqoob et al., 1994;
Griesmacher et al., 1995;
Niskanen et al., 1995;
Laaksonen et al., 1996;
Santini et al., 1997;
Laaksonen and Sen, 2000;
Cederberg et al., 2001),
even in patients without complications. Increased oxidized low density
lipo-protein (LDL) or susceptibility to oxidation has also been shown
in diabetes (Collier et al., 1992;
Neri et al., 1994;
Yaqoob et al., 1994;
Griesmacher et al., 1995;
Laaksonen et al., 1996;
Santini et al., 1997).
Despite strong experimental evidence indicating that oxidative stress
may determine the onset and progression of late-diabetes complications
(Baynes, 1991;
Van Dam et al., 1995;
Giugliano et al., 1996),
controversy exists about whether the increased oxidative stress is merely
associative rather than causal in DM. This is partly because measurement
of oxidative stress is usually based on indirect and nonspecific measurement
of products of reactive oxygen species, and partly because most clinical
studies in DM patients have been cross-sectional (Laaksonen
and Sen, 2000).
The mechanisms behind the apparent increased oxidative stress in diabetes
are not entirely clear. Accumulating evidence points to a number of interrelated
mechanisms (Lyons, 1993;
Cameron and Cotter, 1993;
Tesfamariam, 1994;
Cameron et al., 1996),
increasing production of free radicals such as superoxide (Nath
et al., 1984;
Ceriello et al., 1991;
Wolff et al., 1991;
Dandona et al., 1996)
or decreasing antioxidant status (Asayama et al., 1993;
Tsai et al., 1994;
Ceriello et al., 1997;
Santini et al., 1997).
These mechanisms include glycoxidation (Hunt et al.,
1990;
Wolff et al., 1991)
and formation of advanced glycation products (AGE) (Lyons,
1993;
Schleicher et al., 1997),
activation of the polyol pathway (Cameron et al., 1996;
Cameron and Cotter, 1993;
Grunewald et al., 1993;
Kashiwagi et al., 1994;
De Mattia et al., 1994;
Kashiwagi et al., 1996)
and altered cell26 and glutathione redox status (Grunewald
et al., 1993;
Kashiwagi et al., 1994;
De Mattia et al., 1994;
Kashiwagi et al., 1996)
and ascorbate metabolism (Sinclair et al., 1991)
antioxidant enzyme inactivation (Arai et al., 1987;
Blakytny and Harding, 1992;
Kawamura et al., 1992),
and perturbations in nitric oxide and prostaglandin metabolism (Tesfamariam
, 1994;
Maejima et al., 2001).
Large prospective studies (Lakka et al., 1994;
Paffenbarger et al., 1994)
suggest that regular exercise and physical fitness as measured by maximal
oxygen consumption have protective effect on cardiovascular diseases and
mortality. Diabetic patients were not studied, however, and the mechanisms
by which exercise lowers cardiovascular mortality remained unclear. Exercise
as a tool of preventive medicine has been widely recommended, also for
diabetic patients (American Diabetes Association, 1998).
Regular exercise can strengthen antioxidant defenses and may reduce oxidative
stress at rest and after acute exercise (Sen et al.,
1994b;
Sen, 1995;
Kim et al., 1996).
However, the relative benefits or risks of acute and chronic exercise
in relation to oxidative stress in groups with increased susceptibility
to oxidative stress such as diabetic patients are not known enough. Laaksonen
et al. (1996)
recently found increased oxidative stress as measured by plasma thiobarbituric
acid reactive substances (TBARS) at rest and after exercise in young men
with type 1 DM. Physical fitness as measured by maximal oxygen consumption
(VO2 max), however, was strongly inversely correlated with plasma TBARS
in the diabetic men only, suggesting a protective effect of fitness against
oxidative stress.
|
|
|
| MECHANISMS
FOR INCREASED OXIDATIVE STRESS IN DIABETES |
|
Outline |
| |
|
Advanced glycation endproducts
Advanced glycation or glycosylation endproducts (AGEs) are the products
of glycation and oxidation (glycoxidation), which are increased with age,
and at an accelerated rate in diabetes mellitus (Sell
et al., 1992;
Dyer et al., 1993).
In vitro studies have suggested that glycation itself may result in production
of superoxide (Jones et al., 1987;
Sakurai and Tsuchiya, 1988).
Oxidation has been hypothesized to result in generation of superoxide,
H2O2 and through transition metal catalysis, hydroxyl radicals (Wolff
et al., 1991).
Catalase and other antioxidants decrease cross linking and AGE formation
(Elgawish et al., 1996;
Schleicher et al., 1997).
Alterations in glutathione metabolism
Tissue glutathione plays a central role in antioxidant defense (Sen
and Hanninen, 1994;
Meister, 1995).
Reduced glutathione detoxifies reactive oxygen species such as hydrogen
peroxide and lipid peroxides directly or in a glutathione peroxidase (GPX)
catalyzed mechanism. Glutathione also regenerates the major aqueous and
lipid phase antioxidants, ascorbate and a-tocopherol. Glutathione reductase
(GRD) catalyzes the NADPH dependent reduction of oxidized glutathione,
serving to maintain intracellular glutathione stores and a favorable redox
status. Glutathione-S-transferase (GST) catalyzes the reaction between
the -SH group and potential alkylating agents, rendering them more water
soluble and suitable for transport out of the cell. GST can also use peroxides
as a substrate (Mannervik and Danielson, 1988).
Glutathione homeostasis
Type 2 diabetic patients had decreased erythrocyte GSH and increased GSSG
levels (De Mattia et al., 1994;
Jain and McVie, 1994).
Blood GSH was significantly decreased in different phases of type 2 DM
such as: glucose intolerance and early hyperglycemia (Vijayalingam
et al., 1996),
within two years of diagnosis and before development of complications
(Sundaram et al., 1996)
and in poor glycemic control (Peuchant et al., 1997).
Red cells from type 2 DM patients had decreased GSH levels, impaired gamma-glutamyl
transferase activity and impaired thiol transport (Yoshida
et al., 1995).
Treatment with an antidiabetic agent for 6 months corrected these changes.
Thornalley et al. (1996)
found an inverse correlation between erythrocyte GSH levels and the presence
of DM complications in type 1 and 2 DM patients. However, most studies
have also found decreased blood or red cell glutathione levels in type
2 DM patients. Less firm conclusions can be drawn in type 1 DM patients.
It has to be clarified whether the levels are decreased in patients without
complications and whether patients with complications have even lower
levels. The pathophysiological significance of decreased glutathione levels
in DM remains to be shown.
Glutathione dependent enzymes
Walter et al. (1991)
found no difference in whole blood GRD activity in type 1 and type 2 DM
patients compared to non-diabetic control patients. Muruganandam
et al. (1992)
also found normal red cell GRD enzyme kinetics in type 1 DM patients.
On the other hand, blood GRD activity was lower in children with type
1 DM compared to healthy children (Stahlberg and Hietanen,
1991).
A large number of studies have shown that red blood cell, whole blood
and leukocyte, glutathione peroxidase (GPX) activity was similar in type
1 and type 2 DM patients compared to control groups (Walter
et al., 1991;
Leonard et al., 1995;
Akkus et al., 1996).
On the other hand, erythrocyte GPX activity was also impaired in Asian
diabetic patients (Tho and Candlish, 1987).
In type 1 DM plasma selenium levels were normal, but red cell selenium
content and GPX activity were decreased (Osterode et
al., 1996).
Normal red cell GST enzyme kinetics were found in type 1 DM patients (Muruganandam
et al., 1992).
GST activity has been reported to be decreased in heart and liver (McDermott
et al., 1994).
Changes in glutathione dependent enzymes in experimental diabetic models
have been contradictory. Most studies show tissue and time dependent changes
in enzyme activity. Even taking these factors into account, no consensus
can be found among studies about the impact of DM on glutathione dependent
enzyme activity. Changes in glutathione dependent enzymes in diabetic
patients are also inconsistent. Differences in results cannot be completely
explained by study methodology.
Impairment of superoxide dismutase and catalase activity
Superoxide dismutase (SOD) and catalase are also major antioxidant
enzymes. SOD exists in three different isoforms. Cu,Zn-SOD is mostly in
the cytosol and dismutates superoxide to hydrogen peroxide. Extracellular
(EC) SOD is found in the plasma and extracellular space. Mn-SOD is located
in mitochondria. Catalase is a hydrogen peroxide decomposing enzyme mainly
localized to peroxisomes or microperoxisomes. Superoxide may react with
other reactive oxygen species such as nitric oxide to form highly toxic
species such as peroxynitrite, in addition to direct toxic effects (Tesfamariam,
1994).
Peroxynitrite reacts with the tyrosine residues in proteins resulting
with the nitrotyrosine production in plasma proteins, which is considered
as an indirect evidence of peroxynitrite production and increased oxidative
stress. Although nitrotyrosine was not detectable in the plasma of healthy
controls, nitrotyrosine was found in the plasma of all type 2 diabetic
patients examined. Consistent with these results, plasma nitrotyrosine
values were correlated with plasma glucose concentrations (Ceriello
et al., 2001).
Furthermore, exposure of endothelial cells to high glucose leads to augmented
production of superoxide anion, which may quench nitric oxide. Decreased
nitric oxide levels result with impaired endothelial functions, vasodilation
and delayed cell replication (Giugliano et al., 1996).
Alternatively, superoxide can be dismutated to much more reactive hydrogen
peroxide, which through the Fenton reaction can then lead to highly toxic
hydroxyl radical formation (Wolff et al., 1991).
Decreased activity of cytoplasmic Cu,Zn-SOD and especially mitochondrial
(Mn-) SOD in diabetic neutrophils was found. Consequently superoxide levels
as estimated indirectly by cytochrome c reduction were elevated in neutrophils
from diabetic patients as a result of decreased SOD activity (Nath
et al., 1984).
Major reason for the decreased SOD activity is the glycosylation of Cu,Zn-SOD
which has been shown to lead to enzyme inactivation both in vivo and in
vitro (Arai et al., 1987).
Also Cu,Zn-SOD cleavage and release of Cu++ in vitro resulted in transition
metal catalyzed ROS formation (Kaneto et al., 1996).
Erythrocyte Cu,Zn-SOD activity correlated inversely with indices of glycemic
control in DM patients, however (Tho et al., 1988).
Red cell Cu,Zn/SOD activity has also been found to be decreased in DM
patients (Arai et al., 1987),
(Kawamura et al., 1992).
Glycation may decrease cell-associated EC-SOD, which could predispose
to oxidative damage. Jennings et al. (Jennings et
al., 1991)
found decreased red cell Cu,Zn-SOD activity in type 1 DM patients with
retinopathy compared to type 1 DM patients without microvascular complications
and non-diabetic control subjects. However, there are reports disagreeing
with these findings. Red cell Cu,Zn-SOD activity was similar in type 1
and 2 DM patients compared to normal subjects (Tho
and Candlish, 1987),
(Walter et al., 1991),
(Leonard et al., 1995;
Faure et al., 1995),
irrespective of microvascular complications (Walter
et al., 1991).
Leukocyte SOD activity was similar between type 2 DM patients and healthy
control subjects, despite increased lipid peroxidation and decreased ascorbate
levels (Akkus et al., 1996).
Furthermore, increased red cell SOD activity and serum MDA levels were
reported in patients of type 1 DM with normo- microalbuminuria and retinopathy
compared to healthy subjects (Yaqoob et al., 1994;
Skrha et al., 1994).
Red cell superoxide and catalase activities were decreased in 105 subjects
with impaired glucose tolerance (IGT) and early hyperglycemia and also
in type 2 DM patients (Vijayalingam et al., 1996).
However, in another study red cell catalase and SOD activities were normal
in 26 type 2 DM patients in poor glycemic control (Peuchant
et al., 1997).
EC-SOD activity was found to be similar in type 1 DM patients (Adachi
et al., 1996),
despite somewhat higher plasma EC-SOD levels (MacRury
et al., 1993;
Adachi et al., 1996).
The wide variability among studies does not allow conclusions to be drawn
as to whether SOD isoform or catalase enzyme activities are abnormal in
diabetic patients. Again, differences in methodology or study design do
not completely explain the conflicting findings among studies.
The polyol pathway
Hyperglycemia induces the polyol pathway, resulting in induction of
aldose reductase and production of sorbitol (Figure
1). Importance of the polyol pathway may vary among tissues. Induction
of oxidative stress may occur through many different mechanisms, including
depletion of NADPH and consequent disturbance of glutathione and nitric
oxide metabolism.
Mean red cell GSH and NADPH levels and NADPH/NADP+ and GSH/GSSG ratios
were decreased in 18 type 2 diabetic patients compared to 16 non-diabetic
control subjects (De Mattia et al., 1994;
Bravi et al., 1997).
One week of treatment with the aldose reductase inhibitor Tolrestat improved
the NADPH and GSH levels in those patients whose NADPH levels were depressed
(n=8). Thus in at least a subset of type 2 DM patients activation of the
polyol pathway appears to deplete erythrocyte NADPH and GSH. Similarly
in a recent study aldose reductase inhibitor sorbinil restored nerve concentrations
of antioxidants reduced glutathione (GSH) and ascorbate, and normalized
diabetes-induced lipid peroxidation in streptozotocin-diabetic rats (Obrosova
et al., 2002).
|
|
Figure 1.
Mechanisms for increased oxidative stress in diabetes mellitus.
ROS; reactive oxygen species, GSH; reduced glutathione, GSSG; oxidized
glutathione, GRD; glutathione reductase, GPX; glutathione peroxidase,
AR; aldose reductase (modified from Laaksonen and Sen 2000).
|
| LIPID
PEROXIDATION AND PROTEIN OXIDATION IN DIABETES MELLITUS |
|
Outline |
| |
|
Lipid peroxidation in diabetic patients
Lipid peroxidation end-products very commonly detected by the measurement
of thiobarbituric acid reactive substances (TBARS). This assay has, however,
been criticised for the lack of specificity. Lipid peroxidation as measured
by lipid hydroperoxides (Hermes-Lima et al., 1995)
have been shown to correlate closely with TBARS data in tissue samples.
With proper caution, TBARS measurement may provide meaningful information
(Draper et al., 1993).
Use of TBARS as an index of lipid peroxidation was pioneered by Yagi
et al. (1976),
whose group also showed increased plasma TBARS levels in DM (Sato
et al., 1979)
consistent with other's results (Noberasco et al.,
1991;
Altomare et al., 1992;
Gallou et al., 1993;
Jain and McVie, 1994;
Gugliucci et al., 1994;
Nourooz-Zadeh et al., 1995;
Ozben et al., 1995;
Nacitarhan et al., 1995;
Freitas et al., 1997).
Similarly, increased plasma peroxide concentrations were reported in type
1 and type 2 DM patients (Walter et al., 1991;
Faure et al., 1993).
Diabetic red blood cells (RBC)s were shown to be more susceptible to lipid
peroxidation as measured by TBARS in rats and humans (Godin
et al., 1988;
Fujiwara et al., 1989).
Oxidizability of plasma as measured by lipid hydroperoxides was greater
in DM group, although baseline levels were similar in subjects with normal
glucose tolerance, impaired glucose tolerance, and type 2 DM (Haffner
et al., 1995).
Furthermore, plasma TBARS level was significantly increased in 2 DM with
the duration of disease and development of complications (Sundaram
et al., 1996).
Liposomes constructed from red cell membranes of DM patients were highly
sensitive to superoxide induced lipid peroxidation (Urano
et al., 1991).
SOD and vitamin E inhibited lipid peroxidation. MDA levels showed a significant
correlation with glycosylated Hb. LDL lipid peroxidation was increased
in 19 poorly controlled diabetic patients compared to age and gender matched
subjects (Watala and Winocour, 1992).
The formation of conjugated dienes reflect early events of lipid peroxidation
(Ahotupa et al., 1998).
Spectrophotometric assay of conjugated dienes, however, does not provide
information on hydroperoxides in samples. Serum levels of a conjugated
diene isomer of linoleic acid were higher in DM patients with microalbuminuria
than control subjects (Collier et al., 1992).
Plasma TBARS were elevated in women but not men in a study investigating
lipid peroxidation in 56 young adult type 1 DM and 56 matched non-diabetic
control subjects (Evans and Orchard, 1994).
Similarly a recent report by Marra et al. (2002)
showed that higher lipid peroxidation measured as lipid hydroperoxide,
total conjugated diene coupled with lower total plasma antioxidant capacity
at the early stage of type 1 diabetes, especially in women, which may
suggest the increased susceptibility of diabetic women to cardiovascular
complications. Furthermore lipid peroxidation was increased and ascorbate
levels were decreased in leukocytes from 53 type 2 DM patients compared
to 34 age matched control subjects (Akkus et al., 1996).
Serum MDA levels were higher in 20 patients with newly diagnosed type
2 DM than in matched controls (Armstrong et al., 1996).
RBC free and total MDA levels were elevated in 26 poorly controlled type
2 DM patients (Peuchant et al., 1997).
After three days of euglycemia maintained by constant insulin and glucose
infusion, free MDA significantly decreased.
The vitamin E/lipid peroxide ratio was a major determinant of LDL susceptibility
to oxidation. MDA levels were higher in DM patients compared to control
subjects. Furthermore, LDL peroxidation was tightly correlated to the
extent of LDL glycation. In men, TBARS was correlated with triglyceride
levels and HbA1, but not in women. Dietary treatment decreased HbA1c and
MDA levels significantly. Lipid hydroperoxides and conjugated dienes were
elevated in 72 patients with well controlled type 1 DM without complications,
independent of metabolic control or diabetes duration (Santini
et al., 1997).
Plasma TBARS but not oxysterols were higher in 14 normolipidemic DM patients
than in control subjects (Mol et al., 1997).
Plasma lipid hydroperoxide levels were substantially higher in 41 type
2 diabetic patients compared to 87 control subjects (Nourooz
Zadeh et al., 1997).
Plasma lipid hydroperoxide levels were similar in diabetic patients with
or without complications as well as in smokers and non?smokers. Plasma
lipid peroxide levels, LPS?stimulated monocyte production of TNF?alpha
and monocyte adhesion to endothelial cells were enhanced in 8 poorly controlled
type 2 DM patients on glyburide therapy compared to 8 healthy subjects
(Desfaits et al., 1998).
Gliclazide administration reversed these abnormalities.
On the other hand, no difference in serum conjugated diene levels between
otherwise healthy diabetic patients and healthy control subjects was noted
(MacRury et al., 1993;
Sinclair et al., 1992;
Jennings et al., 1991),
although conjugated diene levels were increased in 26 diabetic patients
with micro-angiopathy complication (Jennings et al.,
1991).
TBARS levels in both poorly and well controlled type 2 DM patients did
not differ from control subjects, whereas hydroxyl radical formation was
elevated in DM patients (Ghiselli et al., 1992).
Plasma TBARS levels were similar in type 1 DM and type 2 DM patients as
in control subjects (Neri et al., 1994;
Leonard et al., 1995;
Zoppini et al., 1996).
However, MDA was elevated in DM patients with micro-vascular complications
compared to DM patients without complications and matched healthy subjects
(Neri et al., 1994).
Most published studies have found increased lipid peroxidation in both
type 1 and type 2 DM patients. Conflicting results have also been found,
however, and they cannot be explained simply based on study design or
methodology. It is less clear whether lipid peroxidation is increased
in DM even before development of micro- and macrovascular disease. A causal
role for lipid peroxidation in the development of diabetic macro- and
microvascular complications is far from established.
Niskanen et al. (1995)
showed for the first time that plasma TBARS were elevated in 22 patients
with impaired glucose tolerance. After 10 years follow up fasting insulin
and glucose levels were predictive of plasma TBARS levels in multiple
regression analyses, suggesting a role for insulin resistance in inducing
oxidative stress. Supporting these findings, lipid peroxidation was elevated
in 105 subjects with IGT and early hyperglycemia and also in type 2 DM
patients (Vijayalingam et al., 1996).
On the other hand, baseline lipid hydroperoxide levels were similar in
75 subjects with normal glucose tolerance, impaired glucose tolerance,
and type 2 DM (Haffner et al., 1995).
Although results to date on the role of insulin resistance as a mechanism
for increased oxidative stress are intriguing, studies are surprisingly
few. Given the attention focused on insulin resistance in the pathogenesis
of DM and cardiovascular disease in general, future studies should also
address the role of insulin resistance in oxidative stress.
Susceptibility of LDL cholesterol to oxidation
Incubation of LDL cholesterol with glucose at concentrations seen in the
diabetic state increased susceptibility of LDL to oxidation as measured
by TBARS and conjugated diene formation, electrophoretic mobility and
degradation by macrophages (Kawamura et al., 1994;
Bowie et al., 1993).
LDL and RBC membranes isolated from type 1 and type 2 DM patients were
much more susceptible to oxidation than LDL from normal subjects (Bowie
et al., 1993;
Rabini et al., 1994).
Furthermore susceptibility of LDL to oxidation was strongly correlated
with degree of LDL glycosylation (Bowie et al., 1993).
Plasma TRAP (total peroxyl radical trapping potential) was lower and susceptibility
of LDL to oxidation as measured by the lag phase of conjugated diene formation
after initiation of LDL oxidation by the addition of copper was greater
in poorly controlled type 1 diabetic subjects than in normal control subjects
(Tsai et al., 1994).
In contrast, there was no difference between type 1 diabetic patients
and non-diabetic subjects in the susceptibility of LDL and VLDL cholesterol
to oxidation in a number of studies (Gugliucci et al.,
1994;
O-Brien et al., 1995;
Jenkins et al., 1996;
Mol et al., 1997).
Although, there was no difference between the groups for LDL vitamin E
content, LDL fatty acid composition in cholesterol esters or triglycerides,
LDL glycation was elevated in the type 1 DM subjects (O-Brien
et al., 1995).
Most studies have found increased susceptibility of
LDL cholesterol to oxidation in DM patients, although some well-designed
studies have had conflicting results. Studies carried out to date do not
allow firm conclusions to be drawn about whether LDL is more susceptible
to oxidation in DM patients without complications than in healthy subjects,
or about what effect complications and glycemic control have on the susceptibility
of LDL to oxidation.
Autoantibodies to oxidized cholesterol
Type 1 and type 2 DM patients had significantly higher antibody ratio
(calculated as the ratio of antibodies against modified versus native
LDL) than control subjects for Cu++?oxidized LDL and malondialdehyde?modified
LDL (Bellomo et al., 1995;
Festa et al. 1998;
Griffin et al., 1997).
In contrast, in early diagnosed or 10 years follow up
type 1 DM patients, levels of serum autoantibodies to oxidized LDL cholesterol
or malondialdehyde?modified LDL were similar compared to healthy control
subjects (Uusitupa et al., 1996;
Mironova et al., 1997;
Korpinen et al., 1997).
Furthermore, in a study performed among DM patients with normo- and macroalbuminuria
with a long duration of diabetes and healthy subjects, antibody levels
against malondialdehyde?modified LDL did not differ among normoalbuminuric
DM, albuminuric DM and control subjects (Korpinen et
al., 1997).
In a very recent study, increased ratios of oxidized LDL antibodies were
detected in type 2 diabetics only with macrovascular disease (Hsu
et al., 2002).
No clear consensus has been found concerning the presence
of increased oxidized LDL antibodies for LDL cholesterol oxidizability
or especially for indices of plasma or serum lipid peroxidation in DM
patients. Although interesting results linking oxidized LDL antibodies
to carotid atherosclerosis in the general population have been published
(Salonen et al., 1992),
similar conclusions cannot be drawn from studies in diabetic patients.
Whether this is an argument against increased oxidative stress or its
role in the pathogenesis of atherosclerosis in DM or against the use of
oxidized LDL autoantibodies as a marker of lipid peroxidation in DM remains
unclear.
Protein Oxidation in diabetic patients
Proteins are an important target for oxidative challenge. Reactive oxygen
species modify amino acid side chains of proteins such as arginine, lysine,
threonine and proline residues to form protein carbonyls. They can be
readily measured by the reaction with 2,4-dinitrophenyl hydrazine using
spectrophotometric, immunohistochemical and radioactive counting methods.
Protein carbonyl content is the most widely used marker of oxidative modification
of proteins and suggested to be a reliable marker of oxidative stress
(Chevion et al.,
2000). Elevated protein carbonyl levels were detected both in type
1 and type 2 and also in experimental diabetes (Dominguez
et al., 1998;
Cakatay et al., 2000;
Telci et al., 2000;
Jang et al., 2000;
Cederberg et al., 2001).
Furthermore, protein carbonyl content is well correlated with the complications
of diabetes (Altomare et al., 1997).
In addition to lipid and protein oxidation, oxidative
damage of DNA has been reported in diabetic patients. Type 1 and type
2 DM patients have significantly higher levels of 8-hydroxydeoxyguanosine,
indicator of oxidative damage of DNA, in mononuclear cells (Dandona
et al., 1996).
These changes might contribute to atherogenesis in DM and to the microangiopathic
complications of the disease.
|
|
|
| EXERCISE,
PHYSICAL FITNESS AND OXIDATIVE STRESS IN DIABETES MELLITUS |
|
Outline |
| |
|
Oxidative stress is implicated in the accelerated atherosclerosis and
microvascular complications of diabetes mellitus. Furthermore, physical
exercise may acutely induce oxidative damage, although regular training
appears to enhance antioxidant defenses, and in some animal studies, it
has decreased lipid peroxidation.
Exercise is a major therapeutic modality in the treatment of DM (American
Diabetes Association, 1998;
Laaksonen et al., 2000).
To maximize the benefits of exercise, it is important to understand the
effect of acute and long term physical exercise on oxidative stress and
antioxidant defenses in diabetes. With these goals in mind, we recruited
9 otherwise healthy type 1 DM and 13 control men aged 20-30 y (Laaksonen
et al., 1996;
Atalay et al., 1997).
The subjects rode for 40 min on a bicycle ergometer at 60% of their VO2
max after a five min warm up. Blood samples were drawn at rest and immediately
after exercise. We used as measures of oxidative stress plasma TBARS,
and in response to exercise changes in GSSG levels and the GSSG/TGSH (total
glutathione) ratio. For indices of antioxidant defenses, blood TGSH and
GSSG levels and red cell GPX, GRD, GST, superoxide and catalase activities
were measured.
Red cell GRD activity at rest was 15% higher in the diabetic group (P<0.05).
However, erythrocyte Cu,Zn-SOD and catalase activities at rest were significantly
lower in the diabetic group. Acute exercise increased erythrocyte Se-GPX
activity modestly in the control group, but not in the IDDM group. Post-exercise
Se-GPX activity was significantly higher in the control group compared
to the IDDM group. Although acute exercise did not significantly affect
GRD activity because of the higher resting values, post-exercise GRD activity
was also higher in the IDDM group compared to the control group. Erythrocyte
GST, Cu,Zn-SOD and catalase activities were similar in control and DM
group after exercise (Atalay et al., 1997).
We found increased plasma TBARS in the diabetic men both at rest and
after exercise, showing for the first time increased exercise induced
oxidative stress in DM (Laaksonen and Sen, 2000).
These results also support previous studies suggesting that type 1 DM
patients have increased lipid peroxidation even in the absence of complications.
Decreased Cu,Zn-SOD activity coupled with increased superoxide production
(Nath et al., 1984;
Ceriello et al., 1991;
Wolff et al., 1991;
Dandona et al., 1996)
could exacerbate oxidative stress, especially if not compensated with
increased catalase or Se-GPX activity. Superoxide may react with other
reactive oxygen species such as nitric oxide to form highly toxic species
such as peroxynitrite, in addition to direct toxic effects (Tesfamariam,
1994).
Alternatively, superoxide can be dismutated to the much more reactive
hydrogen peroxide, which through the Fenton reaction can then lead to
highly toxic hydroxyl radical formation (Wolff et al.,
1991).
Thus decreased catalase activity could also contribute to the increased
oxidative stress found in the type 1 DM subjects. Increased glucose and
hydrogen peroxide levels (Ou and Wolff, 1994)
have also been shown to inactivate catalase. As reviewed above, decreased
red cell SOD and catalase activity have often, but not always, been found
in DM patients.
Increased blood TGSH levels in the DM men could represent an adaptive
response to increased oxidative stress, mediated possibly in part through
increased red cell GRD activity. Most other studies have found either
decreased or unchanged glutathione levels in DM patients. Relatively few
studies have examined glutathione levels in type 1 patients. Frequently,
older patients have complications, or have been poorly described with
respect to presence of diabetic complications or glycemic control. In
the study by Di Simplicio et al. (1995),
however, type 1 DM patients without complications appeared to have increased
platelet GSH.
The strongly negative association between plasma TBARS and VO2 max suggests
that good physical fitness may have a protective role against oxidative
stress. The intriguing question - can lipid peroxidation be decreased
through regular training in diabetes - is thus raised. If so, this may
have far-reaching clinical implications, and the role of oxidative stress
in the development of diabetic micro- and macrovascular complications
needs to be firmly established.
In a recent study in streptozotosin-induced experimental diabetic rats,
our group showed that endurance training decreased lipid peroxidation
measured by TBARS level in vastus lateralis muscle and increased glutathione
peroxidase in red gastrocnemius muscle (Gul et al.,
2002).
However, endurance training increased conjugated dienes and decreased
glutathione peroxidase activity in heart. Consistent with these results,
decreased levels of cardiac antioxidants have been previously observed
in endurance trained healthy rats (Kihlstrom et al.,
1989).
Acute exhaustive exercise induced oxidative stress measured as increased
TBARS level in liver and increased dienes in heart. Increased TBARS levels
in liver of untrained diabetic rats after acute exhaustive exercise are
in agreement with our previous study carried out in normal rats (Khanna
et al., 1999).
These results suggest that despite the adverse effects in heart, endurance
training appears to up-regulate glutathione dependent antioxidant defense
in skeletal muscle in experimental DM.
|
|
|
| CONCLUSION |
|
Outline |
|
Diabetes mellitus is associated with a markedly increased mortality from
coronary heart disease, not explainable by traditional risk factors. Although
data are not yet conclusive, oxidative stress has been increasingly implicated
in the pathogenesis of diabetic micro- and macrovascular disease. Some
evidence also supports a role of physical fitness in decreasing lipid
peroxidation. If regular physical exercise can be shown to have a protective
effect against oxidative stress in DM, this may have direct impact on
the use of physical exercise as a safe therapeutic modality in diabetes.
|
|
|
| ACKNOWLEDGMENTS |
|
Outline |
|
This work was partly supported by research grants from
the Finnish Ministry of Education and Juho Vainio Foundation. David E.
Laaksonen was supported by the TULES Graduate School, Academy of Finland.
The authors thank Ms Merja Saastamoinen for the editorial assistance.
|
|
|
|
AUTHORS BIOGRAPHY:
Mustafa ATALAY
Employment: Senior researcher, Ohio State Univ., Medical Center Columbus,
OH, USA. Depart. of Physiology, Univ. of Kuopio, FIN.
Degrees: MD, Univ.of Ankara, TUR, 1986. Specialization, 1992, State
Hospit. of Ankara. MPH, 1995, Univ. of Kuopio, FIN. PhD, 1998, Univ. of
Kuopio, FIN. Assoc.Prof.,1999.
Research interest:Exercise induced oxidative stress and antioxidant
defenses. Redox control of angiogenesis.
E-mail: Mustafa.Atalay@uku.fi
atalay-1@medctr.osu.edu
David
E. LAAKSONEN
Employment: Researcher and Resident, Depart. of Medicine, Kuopio
Univ. Hospital and Depart. of Physiology, Univ. of Kuopio, FIN.
Degrees: BA in Biology and Spanish,1985, Rice Univ., Houston, TX.
MD, 1990, Univ. of Texas . MPH, 2001, Univ. of Kuopio, FIN.
Research interests: Physical activity, oxidative, stress nutrition,
the metabolic syndrome
E mail: David.Laaksonen@uku.fi
|
|
|